Literature DB >> 7489755

The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen.

H A Stephens1, A E Brown, D Chandanayingyong, H K Webster, M Sirikong, P Longta, R Vangseratthana, D M Gordon, S Lekmak, E Rungruang.   

Abstract

In this study, we examined the correlation between the frequency of allelic variants of the class II human leukocyte antigen (HLA) DR, DQ and DP gene loci and the quantitative humoral immune response observed in 71 Thai volunteers, subsequent to vaccination with a conjugated subunit vaccine. This vaccine was designed to induce antibodies directed against the immunodominant repeat region of the Plasmodium falciparum circumsporozoite (CS) protein. The presence of the DPB1*0501, a relatively common allele in Asian populations, was found to be associated with high vaccine-induced CS repeat-specific antibody responses in the volunteers. Given the increasing focus on the use of subunit vaccines in the control of infectious diseases, consideration of the influence of class II allele frequencies in ethnically diverse recipient populations may be important.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489755     DOI: 10.1002/eji.1830251123

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

3.  HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

Authors:  K M Baldwin; P K Ehrenberg; A Geretz; H A Prentice; S Nitayaphan; S Rerks-Ngarm; J Kaewkungwal; P Pitisuttithum; R J O'Connell; J H Kim; R Thomas
Journal:  Tissue Antigens       Date:  2015-02

4.  HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.

Authors:  Heather A Prentice; Georgia D Tomaras; Daniel E Geraghty; Richard Apps; Youyi Fong; Philip K Ehrenberg; Morgane Rolland; Gustavo H Kijak; Shelly J Krebs; Wyatt Nelson; Allan DeCamp; Xiaoying Shen; Nicole L Yates; Susan Zolla-Pazner; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Guido Ferrari; M Juliana McElrath; David C Montefiori; Robert T Bailer; Richard A Koup; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Peter B Gilbert; Jerome H Kim; Rasmi Thomas
Journal:  Sci Transl Med       Date:  2015-07-15       Impact factor: 17.956

5.  Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis.

Authors:  Toolika Singh; Michaela Fakiola; Joyce Oommen; Akhil Pratap Singh; Abhishek K Singh; Noel Smith; Jaya Chakravarty; Shyam Sundar; Jenefer M Blackwell
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

6.  Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Authors:  Nathaniel D Lambert; Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Vernon Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

7.  Multiple antigen peptide vaccines against Plasmodium falciparum malaria.

Authors:  Babita Mahajan; Jay A Berzofsky; Robert A Boykins; Victoria Majam; Hong Zheng; Rana Chattopadhyay; Patricia de la Vega; J Kathleen Moch; J David Haynes; Igor M Belyakov; Hira L Nakhasi; Sanjai Kumar
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

8.  Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.

Authors:  Armead H Johnson; Rose G F Leke; Nancy R Mendell; Dewon Shon; Young Ju Suh; Dennis Bomba-Nkolo; Viviane Tchinda; Samuel Kouontchou; Lucy W Thuita; Anne Marie van der Wel; Alan Thomas; Anthony Stowers; Allan Saul; Ainong Zhou; Diane W Taylor; Isabella A Quakyi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

10.  A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.

Authors:  P N Fonjungo; I M Elhassan; D R Cavanagh; T G Theander; L Hviid; C Roper; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.